Drug Shortage Report for MYLAN-INDAPAMIDE

Last updated on 2024-07-16 History
Report ID 232575
Drug Identification Number 02240067
Brand name MYLAN-INDAPAMIDE
Common or Proper name INDAPAMIDE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) INDAPAMIDE
Strength(s) 1.25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100BT
ATC code C03BA
ATC description LOW-CEILING DIURETICS, EXCL THIAZIDES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-07-15
Actual start date
Estimated end date 2024-08-06
Actual end date
Shortage status Actual shortage
Updated date 2024-07-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2024-07-16 English Compare
v2 2024-07-09 French Compare
v1 2024-07-09 English Compare

Showing 1 to 3 of 3